Eleven Biotherapeutics Inc (NASDAQ:EBIO) is on the brink of a rebranding transformation. As of tomorrow, this firm will be Eleven no longer, instead assuming …
Eleven Biotherapeutics Inc (NASDAQ:EBIO) shares are jumping up like wildfire today on back of an encouraging Phase 3 trial data preview in bladder …
Eleven Biotherapeutics Inc (NASDAQ:EBIO) shares rose over 11% this morning after the company entered into a definitive share purchase agreement under which Eleven Biotherapeutics …
LinkedIn Corp (NYSE:LNKD) is up a whopping 48% after Microsoft agreed to buy the company for $26.2 billion in cash.
The biotech sector has had a cruel start to the year. The Nasdaq Biotechnology Index (IBB) is down 19% so far in 2016, …
